EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Lauric Acid Overcomes Hypoxia-Induced Gemcitabine Chemoresistance in Pancreatic Ductal Adenocarcinoma

Tadataka Takagi, Rina Fujiwara-Tani, Shiori Mori, Shingo Kishi, Yukiko Nishiguchi, Takamitsu Sasaki, Ruiko Ogata, Ayaka Ikemoto, Rika Sasaki, Hitoshi Ohmori, Yi Luo, Ujjal Kumar Bhawal iD und 2 weitere

International Journal of Molecular Sciences · 2023

DOI: 10.3390/ijms24087506 ↗

Kurz gefasst

Fachartikel in der Zeitschrift International Journal of Molecular Sciences, 2023. Verfasst von Tadataka Takagi und 13 weiteren Autor:innen. Beteiligte Einrichtung: Department of Molecular Pathology, Nara Medical University, Kashihara 634-8521, Japan. Hauptthemen laut MEDLINE: Carcinoma, Pancreatic Ductal, Pancreatic Neoplasms. Die Arbeit wurde bisher 20-mal zitiert (Crossref) und nennt 50 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Ministry of Education, Culture, Sports, Science and Technology.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Although gemcitabine (GEM) is widely used in chemotherapy for pancreatic ductal adenocarcinoma (PDA), drug resistance restricts its clinical effectiveness. To examine the mechanism of GEM resistance, we established two GEM-resistant cell lines from human PDA cells by continuous treatment with GEM and CoCl2-induced chemical hypoxia. One resistant cell line possessed reduced energy production and decreased mitochondrial reactive oxygen species levels, while the other resistant cell line possessed increased stemness. In both cell lines, ethidium bromide-stained mitochondrial DNA levels decreased, suggesting mitochondrial DNA damage. Inhibition of hypoxia-inducible factor-1α in both cell lines did not restore the GEM sensitivity. In contrast, treatment of both cell types with lauric acid (LAA), a medium-chain fatty acid, restored GEM sensitivity. These results suggest that decreased energy production, decreased mitochondrial reactive oxygen species levels, and increased stemness associated with mitochondrial damage caused by GEM lead to GEM resistance, and that hypoxia may promote this process. Furthermore, forced activation of oxidative phosphorylation by LAA could be a tool to overcome GEM resistance. Clinical verification of the effectiveness of LAA in GEM resistance is necessary in the future.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Carcinoma, Pancreatic DuctalPancreatic NeoplasmsHumansGemcitabineDeoxycytidineDrug Resistance, NeoplasmReactive Oxygen SpeciesCell Line, TumorDNA, MitochondrialApoptosisLauric Acids

Stichwörter der Autor:innen

drug resistancegemcitabinehypoxiamitochondriapancreatic cancer

Substanzen

GemcitabineDeoxycytidineReactive Oxygen SpeciesDNA, Mitochondriallauric acidLauric Acids

Autor:innen und Institutionen

  • Department of Molecular Pathology, Nara Medical University, Kashihara 634-8521, Japan.
  • Department of Surgery, Nara Medical University, Kashihara 634-8522, Japan.
  • Jiangsu Province Key Laboratory of Neuroregeneration, Nantong University, 19 Qixiu Road, Nantong 226001, China.
  • Department of Biochemistry and Molecular Biology, Nihon University School of Dentistry at Matsudo, Matsudo 271-8587, Japan.
  • Department of Pharmacology, Saveetha Dental College, Saveetha Institute of Medical and Technical Sciences, Chennai 600077, India.

ORCID-Profile: Ujjal Kumar Bhawal, Hiroki Kuniyasu

Förderung

  • Ministry of Education, Culture, Sports, Science and Technology

Zitieren

APA

Takagi, T., Fujiwara-Tani, R., Mori, S., Kishi, S., Nishiguchi, Y., Sasaki, T., Ogata, R., Ikemoto, A., Sasaki, R., Ohmori, H., Luo, Y., Bhawal, U. K., Sho, M., & Kuniyasu, H. (2023). Lauric Acid Overcomes Hypoxia-Induced Gemcitabine Chemoresistance in Pancreatic Ductal Adenocarcinoma. International Journal of Molecular Sciences. https://doi.org/10.3390/ijms24087506

Vancouver

Takagi T, Fujiwara-Tani R, Mori S, Kishi S, Nishiguchi Y, Sasaki T, et al. Lauric Acid Overcomes Hypoxia-Induced Gemcitabine Chemoresistance in Pancreatic Ductal Adenocarcinoma. International Journal of Molecular Sciences. 2023. doi:10.3390/ijms24087506

BibTeX
@article{Takagi2023,
  author = {Takagi, Tadataka and Fujiwara-Tani, Rina and Mori, Shiori and Kishi, Shingo and Nishiguchi, Yukiko and Sasaki, Takamitsu and Ogata, Ruiko and Ikemoto, Ayaka and Sasaki, Rika and Ohmori, Hitoshi and Luo, Yi and Bhawal, Ujjal Kumar and Sho, Masayuki and Kuniyasu, Hiroki},
  title = {Lauric Acid Overcomes Hypoxia-Induced Gemcitabine Chemoresistance in Pancreatic Ductal Adenocarcinoma},
  journal = {International Journal of Molecular Sciences},
  year = {2023},
  doi = {10.3390/ijms24087506}
}
Kostenlos starten →